TickerFacts.

TFA Therapeutics, Inc. (RAJAF): Cash & Equivalents

Annual figures by period end, from SEC filings.

$3.2K
As of 2025-12-31
-21.6%
3-year compound annual growth
+61.2%
5-year compound annual growth
$99.7K2020-12-31: $2942021-12-31: $99.7K2022-12-31: $6.6K2023-12-31: $23.1K2024-12-31: $37.3K2025-12-31: $3.2K$3.2K
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$3.2K-91.4%2026-05-15, Balance as of period end
2024-12-31$37.3K+61.4%2026-05-15, Balance as of period end
2023-12-31$23.1K+248.6%2025-09-23, Balance as of period end
2022-12-31$6.6K-93.4%2025-09-23, Balance as of period end
2021-12-31$99.7Kn/m2023-05-15, Balance as of period end
2020-12-31$294n/a2023-05-15, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
TFA Therapeutics, Inc. (RAJAF)2025-12-31$3.2K-91.4%
Adia Med, Inc. (ADIA)2025-12-31$79.4Kn/m
China Foods Holdings Ltd. (CFOO)2025-12-31$9.9K-74.8%
Nutra Pharma Corp (NPHC)2025-12-31$12.2K-66.6%
Functional Brands Inc. (MEHA)2025-12-31$2.73Mn/m
Cyanotech Corp (CYAN)2025-03-31$257.0K-63.6%
Synergy CHC Corp. (SNYRQ)2025-12-31$2.62M+281.2%
Leef Brands Inc. (LEEEF)2025-12-31$2.19M-19.8%
Mannatech Inc (MTEX)2025-12-31$6.18M-45.7%

Compare RAJAF, ADIA, CFOO, NPHC side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗